Related Experiment Videos

Effects of ergometrine on dopamine receptors

A R Crossman, A O el-Khawad, R J Walker

The Journal of Physiology

|July 1, 1973

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Concurrent chronic administration of a CCK(B) antagonist can decrease tolerance to the ataxic effects of ethanol.

Addiction biology·2010

Anatomic localization of dyskinesia in children with "profound" perinatal hypoxic-ischemic injury.

AJNR. American journal of neuroradiology·2009

Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

Neuropharmacology·2005

Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society·2004

The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.

Experimental neurology·2004

Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.

Experimental neurology·2004

See all related articles